Bellevue Group Ag Recursion Pharmaceuticals, Inc. Transaction History
Bellevue Group Ag
- $6.38 Billion
- Q1 2024
A detailed history of Bellevue Group Ag transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 425,249 shares of RXRX stock, worth $3.04 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
425,249
Previous 174,557
143.62%
Holding current value
$3.04 Million
Previous $1.72 Million
146.31%
% of portfolio
0.07%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding RXRX
# of Institutions
260Shares Held
192MCall Options Held
787KPut Options Held
1.52M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl24.6MShares$176 Million1.75% of portfolio
-
Baillie Gifford & CO24.1MShares$172 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$115 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$88.2 Million0.0% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V710.4MShares$74.5 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.29B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...